Amrutanjan Health Care Limited

NSEI:AMRUTANJAN Aktierapport

Börsvärde: ₹18.5b

Amrutanjan Health Care Förvaltning

Förvaltning kriterier kontrolleras 2/4

Vi har för närvarande inte tillräcklig information om VD:n.

Viktig information

Sambhu Sivalenka

Verkställande direktör

n/a

Total ersättning

VD-lön i procentn/a
Anställning som VD26.2yrs
Ägande av VD13.9%
Ledningens genomsnittliga anställningstidinga uppgifter
Styrelsens genomsnittliga mandatperiod3.8yrs

Senaste uppdateringar av ledningen

Recent updates

Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Feb 18
Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00

Nov 19
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 31
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 17
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

May 31
We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings

Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now

May 03
Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00

Feb 12
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60

Sep 02
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60

Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Aug 19
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60

Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60

Aug 05
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60

Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00

Feb 17
Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Nov 08
Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00

Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60

Aug 18
Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60

Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why

Apr 30
Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why

Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?

Apr 08
Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?

Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years

Mar 11
Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years

Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares

Feb 24
Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares

Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?

Feb 14
Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?

Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?

Feb 12
Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?

Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?

Jan 30
Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?

Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?

Jan 17
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?

Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock

Jan 04
Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock

What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?

Dec 22
What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?

How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?

Dec 09
How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?

If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today

Nov 26
If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today

Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend

Nov 14
Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend

Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio

Oct 28
Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio

Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?

Oct 10
Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?

I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease

Sep 22
I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease

What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?

Sep 01
What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?

Analys av ersättningar till VD

Hur har Sambhu Sivalenka:s ersättning förändrats jämfört med Amrutanjan Health Care:s resultat?
DatumTotal ersättningLönFöretagets resultat
Dec 31 2024n/an/a

₹493m

Sep 30 2024n/an/a

₹475m

Jun 30 2024n/an/a

₹426m

Mar 31 2024n/an/a

₹450m

Dec 31 2023n/an/a

₹440m

Sep 30 2023n/an/a

₹373m

Jun 30 2023n/an/a

₹432m

Mar 31 2023n/an/a

₹398m

Dec 31 2022n/an/a

₹418m

Sep 30 2022n/an/a

₹517m

Jun 30 2022n/an/a

₹588m

Mar 31 2022n/an/a

₹672m

Dec 31 2021n/an/a

₹627m

Sep 30 2021n/an/a

₹631m

Jun 30 2021n/an/a

₹668m

Mar 31 2021n/an/a

₹612m

Dec 31 2020n/an/a

₹589m

Sep 30 2020n/an/a

₹474m

Jun 30 2020n/an/a

₹322m

Mar 31 2020₹13m₹11m

₹251m

Dec 31 2019n/an/a

₹314m

Sep 30 2019n/an/a

₹274m

Jun 30 2019n/an/a

₹257m

Mar 31 2019₹13m₹11m

₹250m

Dec 31 2018n/an/a

₹158m

Sep 30 2018n/an/a

₹168m

Jun 30 2018n/an/a

₹201m

Mar 31 2018₹13m₹11m

₹200m

Ersättning vs marknad: Otillräckliga data för att fastställa om Sambhu s total kompensation är rimlig jämfört med företag av liknande storlek på Indian marknaden.

Ersättning vs inkomst: Ersättningen från Sambhu har varit i linje med företagets resultat under det senaste året.


VD OCH KONCERNCHEF

Sambhu Sivalenka (50 yo)

26.2yrs

Anställning

₹12,759,000

Kompensation

Mr. Sambhu Prasad Sivalenka, B.Tech (USA), M.B.A. (USA) has been the Managing Director of Amrutanjan Health Care Limited and serves as its Executive Chairman since February 13, 2012. He has been Director...


Styrelseledamöter

NamnPositionAnställningKompensationÄgarskap
Sambhu Sivalenka
Executive Chairman & MD26.2yrs₹12.76m13.94%
₹ 2.6b
V. Nagaraj
Non-Executive Independent Directorless than a yearinga uppgifteringa uppgifter
Raja Venkataraman
Independent Non-Executive Director3.8yrs₹1.95minga uppgifter
Ramaa Arikirevula
Non-Executive Non Independent Director1.8yrs₹1.12m7.76%
₹ 1.4b
Govindan Raghavan
Non-Executive & Non Independent Director9.8yrs₹1.50m0.12%
₹ 22.8m
Muralidharan Swayambunathan
Non-Executive Independent Director3.8yrs₹2.07minga uppgifter
Meenalochani Raghunathan
Additional Non-Executive Independent Director2.6yrs₹1.49minga uppgifter

3.8yrs

Genomsnittlig anställningstid

65yo

Genomsnittlig ålder

Erfaren styrelse: AMRUTANJAN s styrelse anses vara erfaren ( 3.8 års genomsnittlig mandatperiod).


Företagsanalys och finansiella data Status

UppgifterSenast uppdaterad (UTC-tid)
Analys av företag2025/03/26 13:57
Aktiekurs vid dagens slut2025/03/26 00:00
Intäkter2024/12/31
Årlig intjäning2024/03/31

Datakällor

Den data som används i vår företagsanalys kommer från S&P Global Market Intelligence LLC. Följande data används i vår analysmodell för att generera denna rapport. Data är normaliserade vilket kan medföra en fördröjning från det att källan är tillgänglig.

PaketUppgifterTidsramExempel US-källa
Företagets finansiella ställning10 år
  • Resultaträkning
  • Kassaflödesanalys
  • Balansräkning
Analytikernas konsensusuppskattningar+3 år
  • Prognos för finansiella poster
  • Analytikernas prismål
Marknadspriser30 år
  • Aktiekurser
  • Utdelningar, splittar och åtgärder
Ägarskap10 år
  • Största aktieägare
  • Insiderhandel
Förvaltning10 år
  • Ledningsgrupp
  • Styrelse och verkställande direktörer
Viktiga utvecklingstendenser10 år
  • Företagsmeddelanden

* Exempel för amerikanska värdepapper, för icke-amerikanska värdepapper används motsvarande regelverk och källor.

Om inget annat anges är all finansiell data baserad på en årsperiod men uppdateras kvartalsvis. Detta kallas data för efterföljande tolv månader (TTM) eller senaste tolv månader (LTM). Lär dig mer om detta.

Analysmodell och snöflinga

Detaljer om den analysmodell som används för att generera denna rapport finns på vår Github-sida, vi har också guider om hur man använder våra rapporter och tutorials på Youtube.

Lär dig mer om det team i världsklass som utformade och byggde analysmodellen Simply Wall St.

Industri- och sektormått

Våra bransch- och sektionsmått beräknas var sjätte timme av Simply Wall St, detaljer om vår process finns tillgängliga på Github.

Källor för analytiker

Amrutanjan Health Care Limited bevakas av 2 analytiker. 0 av dessa analytiker lämnade de uppskattningar av intäkter eller resultat som användes som indata till vår rapport. Analytikernas inskickade estimat uppdateras löpande under dagen.

AnalytikerInstitution
Pranoy KurianCentrum Broking (Non-Insti) Clients
Harini V.FirstCall Research